KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Deferred Tax Liability (2016 - 2026)

AbbVie has reported Non-Current Deferred Tax Liability over the past 14 years, most recently at $2.5 billion for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 3.76% to $2.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, down 3.76% year-over-year, with the annual reading at $2.5 billion for FY2025, 3.76% down from the prior year.
  • Non-Current Deferred Tax Liability was $2.5 billion for Q4 2025 at AbbVie, roughly flat from $2.5 billion in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $3.8 billion in Q1 2021 and troughed at $2.0 billion in Q3 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $2.6 billion (2024), against an average of $2.7 billion.
  • Year-over-year, Non-Current Deferred Tax Liability surged 292.91% in 2021 and then plummeted 45.25% in 2022.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $3.0 billion in 2021, then dropped by 27.22% to $2.2 billion in 2022, then rose by 21.23% to $2.7 billion in 2023, then dropped by 2.86% to $2.6 billion in 2024, then dropped by 3.76% to $2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Non-Current Deferred Tax Liability are $2.5 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.6 billion (Q2 2025).